C. Alexandre, D. Popa, V. Fabre, S. Bouali, P. Venault et al., Early Life Blockade of 5-Hydroxytryptamine 1A Receptors Normalizes Sleep and Depression-Like Behavior in Adult Knock-Out Mice Lacking the Serotonin Transporter, Journal of Neuroscience, vol.26, issue.20, pp.5554-5564, 2006.
DOI : 10.1523/JNEUROSCI.5156-05.2006

A. Andrieux, P. A. Salin, and M. Vernet, The suppression of brain cold-stable microtubules in mice induces synaptic defects associated with neuroleptic-sensitive behavioral disorders, Genes & Development, vol.16, issue.18, pp.2350-2364, 2002.
DOI : 10.1101/gad.223302

A. Andrieux, P. Salin, and A. Schweitzer, Microtubule Stabilizer Ameliorates Synaptic Function and Behavior in a Mouse Model for Schizophrenia, Biological Psychiatry, vol.60, issue.11, pp.1224-1230, 2006.
DOI : 10.1016/j.biopsych.2006.03.048

URL : https://hal.archives-ouvertes.fr/inserm-00380045

M. S. Ansorge, E. Morelli, and J. A. Gingrich, Inhibition of Serotonin But Not Norepinephrine Transport during Development Produces Delayed, Persistent Perturbations of Emotional Behaviors in Mice, Journal of Neuroscience, vol.28, issue.1, pp.199-207, 2008.
DOI : 10.1523/JNEUROSCI.3973-07.2008

A. R. Ase, T. A. Reader, R. Hen, M. Riad, and L. Descarries, knockout, Journal of Neurochemistry, vol.21, issue.3, pp.619-630, 2001.
DOI : 10.1046/j.1471-4159.2001.00437.x

Y. Ayhan, B. Abazyan, and J. Nomura, Differential effects of prenatal and postnatal expressions of mutant human DISC1 on neurobehavioral phenotypes in transgenic mice: evidence for neurodevelopmental origin of major psychiatric disorders, Molecular Psychiatry, vol.115, issue.3, pp.293-306, 2010.
DOI : 10.1038/sj.mp.4001574

J. M. Beaulieu, X. Zhang, R. M. Rodriguiz, T. D. Sotnikova, M. J. Cools et al., Role of GSK3 beta in behavioral abnormalities induced by serotonin deficiency, Proc. Natl. Acad. Sci. USA 105, pp.1333-1338, 2008.

M. Begou, P. Brun, J. B. Bertrand, D. Job, A. Schweitzer et al., Post-pubertal emergence of alterations in locomotor activity in stop null mice, Synapse, vol.177, issue.9, pp.689-697, 2007.
DOI : 10.1002/syn.20409

URL : https://hal.archives-ouvertes.fr/inserm-00379954

M. Begou, J. Volle, and J. B. Bertrand, The stop null mice model for schizophrenia displays cognitive and social deficits partly alleviated by neuroleptics, Neuroscience, vol.157, issue.1, pp.29-39, 2008.
DOI : 10.1016/j.neuroscience.2008.07.080

URL : https://hal.archives-ouvertes.fr/inserm-00375621

C. Belzung, The genetic basis of the pharmacological effects of anxiolytics: a review based on rodent models, Behavioural Pharmacology, vol.12, issue.6, pp.451-460, 2001.
DOI : 10.1097/00008877-200111000-00005

R. A. Bevins and J. Besheer, Object recognition in rats and mice: a one-trial non-matching-to-sample learning task to study 'recognition memory', Nature Protocols, vol.37, issue.3, pp.1306-1311, 2006.
DOI : 10.1038/nprot.2006.205

D. Blackwood, B. Pickard, P. Thomson, K. Evans, D. Porteous et al., Are some genetic risk factors common to schizophrenia, bipolar disorder and depression? evidence fromDISC1, GRIK4 andNRG1, Neurotoxicity Research, vol.41, issue.2, pp.73-83, 2007.
DOI : 10.1007/BF03033484

C. Bouvrais-veret, S. Weiss, A. Andrieux, A. Schweitzer, J. M. Mcintosh et al., Sustained increase of alpha7 nicotinic receptors and choline-induced improvement of learning deficit in STOP knock-out mice, Neuropharmacology, vol.52, issue.8, pp.1691-1700, 2007.
DOI : 10.1016/j.neuropharm.2007.03.015

URL : https://hal.archives-ouvertes.fr/inserm-00379958

E. Brenner, U. Sonnewald, A. Schweitzer, A. Andrieux, and A. Nehlig, Hypoglutamatergic activity in the STOP knockout mouse: A potential model for chronic untreated schizophrenia, Journal of Neuroscience Research, vol.18, issue.15, pp.3487-3493, 2007.
DOI : 10.1002/jnr.21200

URL : https://hal.archives-ouvertes.fr/inserm-00379976

R. Brown and A. J. Silva, Molecular and Cellular Cognition, Cell, vol.117, issue.1, pp.3-4, 2004.
DOI : 10.1016/S0092-8674(04)00295-8

URL : http://doi.org/10.1016/s0092-8674(04)00295-8

P. Brun, M. Begou, and A. Andrieux, Dopaminergic transmission in STOP null mice, Journal of Neurochemistry, vol.65, issue.1, pp.63-73, 2005.
DOI : 10.1016/0165-0173(90)90015-G

URL : https://hal.archives-ouvertes.fr/inserm-00380189

J. Callicott, R. Straub, and L. Pezawas, Variation in DISC1 affects hippocampal structure and function and increases risk for schizophrenia, Proc. Natl Acad. Sci. USA, pp.8627-8632, 2005.
DOI : 10.1073/pnas.0500515102

L. M. Camargo, V. Collura, J. C. Rain, K. Mizuguchi, H. Hermjakob et al., Disrupted in Schizophrenia 1 Interactome: evidence for the close connectivity of risk genes and a potential synaptic basis for schizophrenia, Molecular Psychiatry, vol.114, issue.1, pp.74-86, 2007.
DOI : 10.1016/0169-328X(94)00247-C

A. G. Cardno, E. J. Marshall, and B. Coid, Heritability Estimates for Psychotic Disorders, Archives of General Psychiatry, vol.56, issue.2, pp.162-168, 1999.
DOI : 10.1001/archpsyc.56.2.162

W. T. Carpenter, J. R. Bustillo, G. K. Thaker, J. Van-os, R. F. Krueger et al., The psychoses: Cluster 3 of the proposed meta-structure for DSM-V and ICD-11, Psychological Medicine, vol.102, issue.12, pp.2025-2042, 2009.
DOI : 10.1093/brain/122.4.593

K. Chen, D. P. Holschneider, W. Wu, I. Rebrin, and J. C. Shih, A Spontaneous Point Mutation Produces Monoamine Oxidase A/B Knock-out Mice with Greatly Elevated Monoamines and Anxiety-like Behavior, Journal of Biological Chemistry, vol.279, issue.38, pp.39645-39652, 2004.
DOI : 10.1074/jbc.M405550200

S. J. Clapcote, T. V. Lipina, and J. K. Millar, Behavioral Phenotypes of Disc1 Missense Mutations in Mice, Neuron, vol.54, issue.3, pp.387-402, 2007.
DOI : 10.1016/j.neuron.2007.04.015

N. Craddock and M. J. Owen, The beginning of the end for the Kraepelinian dichotomy, The British Journal of Psychiatry, vol.186, issue.5, pp.364-366, 2005.
DOI : 10.1192/bjp.186.5.364

N. Craddock, M. C. O-'donovan, and M. J. Owen, Genes for Schizophrenia and Bipolar Disorder? Implications for Psychiatric Nosology, Schizophrenia Bulletin, vol.32, issue.1, pp.9-16, 2006.
DOI : 10.1093/schbul/sbj033

P. Delagrange, R. Misslin, T. W. Seale, B. Pfeiffer, S. Rault et al., Effects of S-21007, a potent 5-HT3 partial agonist, in mouse anxiety, Zhongguo Yao Li Xue Bao, vol.20, pp.805-812, 1999.

D. Delotterie, G. Ruiz, J. Brocard, A. Schweitzer, C. Roucard et al., Chronic administration of atypical antipsychotics improves behavioral and synaptic defects of STOP null mice, Psychopharmacology, vol.84, issue.1, pp.131-141, 2010.
DOI : 10.1007/s00213-009-1712-3

URL : https://hal.archives-ouvertes.fr/inserm-00447474

T. Deltheil, B. P. Guiard, and J. Cerdan, Behavioral and serotonergic consequences of decreasing or increasing hippocampus brain-derived neurotrophic factor protein levels in mice, Neuropharmacology, vol.55, issue.6, pp.1006-1014, 2008.
DOI : 10.1016/j.neuropharm.2008.08.001

L. Desbonnet, J. L. Waddington, and C. M. Tuathaigh, Mice mutant for genes associated with schizophrenia: Common phenotype or distinct endophenotypes?, Behavioural Brain Research, vol.204, issue.2, pp.258-273, 2009.
DOI : 10.1016/j.bbr.2009.04.001

M. J. Detke, M. Rickels, and I. Lucki, Active behaviors in the rat forced swimming test differentially produced by serotonergic and noradrenergic antidepressants, Psychopharmacology, vol.101, issue.1, pp.66-72, 1995.
DOI : 10.1007/BF02245592

M. Dziedzicka-wasylewska, A. Faron-gorecka, M. Kusmider, E. Drozdowska, Z. Rogoz et al., Effect of Antidepressant Drugs in Mice Lacking the Norepinephrine Transporter, Neuropsychopharmacology, vol.68, issue.11, pp.2424-2432, 2006.
DOI : 10.1038/sj.npp.1301064

S. L. Eastwood, L. Lyon, L. George, A. Andrieux, D. Job et al., Altered expression of synaptic protein mRNAs in STOP (MAP6) mutant mice, Journal of Psychopharmacology, vol.105, issue.6, pp.635-644, 2007.
DOI : 10.1177/0269881106068825

URL : https://hal.archives-ouvertes.fr/inserm-00380032

M. El-ghundi, B. F. O-'dowd, and S. R. George, Insights into the Role of Dopamine Receptor Systems in Learning and Memory, Reviews in the Neurosciences, vol.18, issue.1, pp.37-66, 2007.
DOI : 10.1515/REVNEURO.2007.18.1.37

V. Fabre, C. Beaufour, and A. Evrard, receptors in knock-out mice lacking the 5-HT transporter, European Journal of Neuroscience, vol.52, issue.Suppl.2, pp.2299-2310, 2000.
DOI : 10.1046/j.1460-9568.2000.00126.x

V. Fournet, M. Jany, and V. Fabre, The deletion of the microtubule-associated STOP protein affects the serotonergic mouse brain network, Journal of Neurochemistry, vol.12, issue.Suppl, pp.1579-1594, 2010.
DOI : 10.1111/j.1471-4159.2010.07064.x

URL : https://hal.archives-ouvertes.fr/inserm-00566974

R. L. Fradley, G. F. O-'meara, R. J. Newman, A. Andrieux, D. Job et al., STOP knockout and NMDA NR1 hypomorphic mice exhibit deficits in sensorimotor gating, Behavioural Brain Research, vol.163, issue.2, pp.257-264, 2005.
DOI : 10.1016/j.bbr.2005.05.012

URL : https://hal.archives-ouvertes.fr/inserm-00380197

K. B. Franklin and G. Paxinos, The Mouse Brain in Stereotaxic Coordinates, 1997.

J. S. Franowicz, L. E. Kessler, C. M. Borja, B. K. Kobilka, L. E. Limbird et al., Mutation of the alpha2A-adrenoceptor impairs working memory performance and annuls cognitive enhancement by guanfacine, J. Neurosci, vol.22, pp.8771-8777, 2002.

M. Fukui, R. M. Rodriguiz, J. Zhou, S. X. Jiang, L. E. Phillips et al., Vmat2 Heterozygous Mutant Mice Display a Depressive-Like Phenotype, Journal of Neuroscience, vol.27, issue.39, pp.10520-10529, 2007.
DOI : 10.1523/JNEUROSCI.4388-06.2007

I. Gonzalez-burgos and A. Feria-velasco, Serotonin/dopamine interaction in memory formation, Prog. Brain Res, vol.172, pp.603-623, 2008.
DOI : 10.1016/S0079-6123(08)00928-X

C. Gras, B. Amilhon, and E. M. Lepicard, The vesicular glutamate transporter VGLUT3 synergizes striatal acetylcholine tone, Nature Neuroscience, vol.28, issue.3, pp.292-300, 2008.
DOI : 10.1038/nn2052

URL : https://hal.archives-ouvertes.fr/hal-00263930

G. Griebel, R. J. Rodgers, G. Perrault, and D. J. Sanger, The effects of compounds varying in selectivity as 5-HT1A receptor antagonists in three rat models of anxiety, Neuropharmacology, vol.39, issue.10, pp.1848-1857, 2000.
DOI : 10.1016/S0028-3908(00)00074-5

C. Gross, X. Zhuang, K. Stark, S. Ramboz, O. Ronald et al., Serotonin1A receptor acts during development to establish normal anxiety-like behaviour in the adult, Nature, vol.272, issue.6879, pp.396-400, 2002.
DOI : 10.1038/416396a

R. Hanaya, E. Koning, A. Ferrandon, A. Schweitzer, A. Andrieux et al., Deletion of the STOP gene, a microtubule stabilizing factor, leads only to discrete cerebral metabolic changes in mice, Journal of Neuroscience Research, vol.246, issue.4, pp.813-820, 2008.
DOI : 10.1002/jnr.21550

URL : https://hal.archives-ouvertes.fr/inserm-00375633

A. Holmes, D. L. Murphy, and J. N. Crawley, Abnormal behavioral phenotypes of serotonin transporter knockout mice: parallels with human anxiety and depression, Biological Psychiatry, vol.54, issue.10, pp.953-959, 2003.
DOI : 10.1016/j.biopsych.2003.09.003

T. A. Jenkins, J. J. Elliott, T. C. Ardis, M. Cahir, G. P. Reynolds et al., Tryptophan depletion impairs object-recognition memory in the rat: Reversal by risperidone, Behavioural Brain Research, vol.208, issue.2, pp.479-483, 2010.
DOI : 10.1016/j.bbr.2009.12.030

K. A. Jennings, M. K. Loder, and W. J. Sheward, Increased Expression of the 5-HT Transporter Confers a Low- Anxiety Phenotype Linked to Decreased 5-HT Transmission, Journal of Neuroscience, vol.26, issue.35, pp.8955-8964, 2006.
DOI : 10.1523/JNEUROSCI.5356-05.2006

Y. Ji, F. Yang, F. Papaleo, H. X. Wang, W. J. Gao et al., Role of dysbindin in dopamine receptor trafficking and cortical GABA function, Proc. Natl. Acad. Sci. USA, 2009.
DOI : 10.1073/pnas.0904289106

K. Kajitani, M. Thorne, M. Samson, and G. S. Robertson, Nitric oxide synthase mediates the ability of darbepoetin alfa to improve the cognitive performance of STOP null mice, Neuropsychopharmacology, vol.35, pp.1718-1728, 2010.

A. V. Kalueff, M. A. Fox, P. S. Gallagher, and D. L. Murphy, Hypolocomotion, anxiety and serotonin syndrome-like behavior, 2007.

A. V. Kalueff, J. D. Olivier, L. J. Nonkes, and J. R. Homberg, Conserved role for the serotonin transporter gene in rat and mouse neurobehavioral endophenotypes, Neuroscience & Biobehavioral Reviews, vol.34, issue.3, pp.373-386, 2010.
DOI : 10.1016/j.neubiorev.2009.08.003

R. C. Kessler, W. T. Chiu, O. Demler, K. R. Merikangas, and E. E. Walters, Prevalence, Severity, and Comorbidity of 12-Month DSM-IV Disorders in the National Comorbidity Survey Replication, Archives of General Psychiatry, vol.62, issue.6, pp.617-627, 2005.
DOI : 10.1001/archpsyc.62.6.617

D. Kim, T. J. Tolliver, S. Huang, B. J. Martin, A. M. Andrews et al., Altered serotonin synthesis, turnover and dynamic regulation in multiple brain regions of mice lacking the serotonin transporter, Neuropharmacology, vol.49, issue.6, pp.798-810, 2005.
DOI : 10.1016/j.neuropharm.2005.08.010

L. Kokkinidis and H. Anisman, Dissociation of the effects of scopolamine and d-amphetamine on a spontaneous alternation task, Pharmacology Biochemistry and Behavior, vol.5, issue.3, pp.293-297, 1976.
DOI : 10.1016/0091-3057(76)90081-2

H. Kusserow, B. Davies, and H. Hortnagl, Reduced anxiety-related behaviour in transgenic mice overexpressing serotonin1A receptors, Molecular Brain Research, vol.129, issue.1-2, pp.104-116, 2004.
DOI : 10.1016/j.molbrainres.2004.06.028

M. Kvajo, H. Mckellar, P. A. Arguello, L. J. Drew, H. Moore et al., A mutation in mouse Disc1 that models a schizophrenia risk allele leads to specific alterations in neuronal architecture and cognition, Proc. Natl. Acad. Sci. USA 105, pp.7076-7081, 2008.
DOI : 10.1073/pnas.0802615105

L. Lanfumey, R. Mongeau, C. Cohen-salmon, and M. Hamon, Corticosteroid???serotonin interactions in the neurobiological mechanisms of stress-related disorders, Neuroscience & Biobehavioral Reviews, vol.32, issue.6, pp.1174-1184, 2008.
DOI : 10.1016/j.neubiorev.2008.04.006

J. A. Lieberman, D. Perkins, A. Belger, M. Chakos, F. Jarskog et al., The early stages of schizophrenia: speculations on pathogenesis, pathophysiology, and therapeutic approaches, Biological Psychiatry, vol.50, issue.11, pp.884-897, 2001.
DOI : 10.1016/S0006-3223(01)01303-8

S. J. Line, C. Barkus, C. Coyle, K. A. Jennings, R. M. Deacon et al., Opposing alterations in anxiety and species-typical behaviours in serotonin transporter overexpressor and knockout mice, European Neuropsychopharmacology, vol.21, issue.1, pp.108-116, 2010.
DOI : 10.1016/j.euroneuro.2010.08.005

A. Lira, M. Zhou, and N. Castanon, Altered depression-related behaviors and functional changes in the dorsal raphe nucleus of serotonin transporter-deficient mice, Biological Psychiatry, vol.54, issue.10, pp.960-971, 2003.
DOI : 10.1016/S0006-3223(03)00696-6

W. Maier, A. Zobel, and M. Wagner, Schizophrenia and bipolar disorder: differences and overlaps, Current Opinion in Psychiatry, vol.19, issue.2, pp.165-170, 2006.
DOI : 10.1097/01.yco.0000214342.52249.82

F. Masse, B. Petit-demouliere, I. Dubois, M. Hascoet, and M. Bourin, Anxiolytic-like effects of DOI microinjections into the hippocampus (but not the amygdala nor the PAG) in the mice four plates test, Behavioural Brain Research, vol.188, pp.291-297, 2008.
DOI : 10.1016/j.bbr.2007.11.005

A. Merenlender-wagner, R. Pikman, E. Giladi, A. Andrieux, and I. Gozes, NAP (davunetide) enhances cognitive behavior in the STOP heterozygous mouse???A microtubule-deficient model of schizophrenia, Peptides, vol.31, issue.7, pp.1368-1373, 2010.
DOI : 10.1016/j.peptides.2010.04.011

URL : https://hal.archives-ouvertes.fr/inserm-00498115

M. J. Millan, A. Dekeyne, M. Papp, L. Rochelle, C. D. Macsweeny et al., S33005, a novel ligand at both serotonin and norepinephrine transporters: II. Behavioral profile in comparison with venlafaxine, reboxetine, citalopram, and clomipramine, J. Pharmacol. Exp. Ther, vol.298, pp.581-591, 2001.

K. Mirnics, F. A. Middleton, D. A. Lewis, and P. Levitt, Analysis of complex brain disorders with gene expression microarrays: schizophrenia as a disease of the synapse, Trends in Neurosciences, vol.24, issue.8, pp.479-486, 2001.
DOI : 10.1016/S0166-2236(00)01862-2

E. Morice, J. Billard, C. Denis, F. Mathieu, C. Betancur et al., Parallel Loss of Hippocampal LTD and Cognitive Flexibility in a Genetic Model of Hyperdopaminergia, Neuropsychopharmacology, vol.41, issue.10, pp.2108-2116, 2007.
DOI : 10.1038/sj.npp.1301354

URL : https://hal.archives-ouvertes.fr/inserm-00166900

J. Morris, G. Kandpal, L. Ma, and C. Austin, DISC1 (Disrupted-In-Schizophrenia 1) is a centrosome-associated protein that interacts with MAP1A, MIPT3, ATF4/5 and NUDEL: regulation and loss of interaction with mutation, Human Molecular Genetics, vol.12, issue.13, pp.1591-1608, 2003.
DOI : 10.1093/hmg/ddg162

R. M. Murray, P. Sham, J. Van-os, J. Zanelli, M. Cannon et al., A developmental model for similarities and dissimilarities between schizophrenia and bipolar disorder. Schizophrenia Res, pp.405-416, 2004.

A. Nieoullon, Dopamine and the regulation of cognition and attention, Progress in Neurobiology, vol.67, issue.1, pp.53-83, 2002.
DOI : 10.1016/S0301-0082(02)00011-4

URL : https://hal.archives-ouvertes.fr/hal-00307886

M. Niwa, A. Kamiya, and R. Murai, Knockdown of DISC1 by In Utero Gene Transfer Disturbs Postnatal Dopaminergic Maturation in the Frontal Cortex and Leads to Adult Behavioral Deficits, Neuron, vol.65, issue.4, pp.480-489, 2010.
DOI : 10.1016/j.neuron.2010.01.019

J. D. Olivier, M. G. Van-der-hart, and R. P. Van-swelm, A study in male and female 5-HT transporter knockout rats: An animal model for anxiety and depression disorders, Neuroscience, vol.152, issue.3, pp.573-584, 2008.
DOI : 10.1016/j.neuroscience.2007.12.032

G. A. Ordway, C. A. Stockmeier, G. W. Cason, and V. Klimek, Pharmacology and distribution of norepinephrine transporters in the human locus coeruleus and raphe nuclei, J. Neurosci, vol.17, pp.1710-1719, 1997.

M. T. Perona, S. Waters, F. S. Hall, I. Sora, K. P. Lesch et al., Animal models of depression in dopamine, serotonin, and norepinephrine transporter knockout mice: prominent effects of dopamine transporter deletions, Behavioural Pharmacology, vol.19, issue.5-6, pp.566-574, 2008.
DOI : 10.1097/FBP.0b013e32830cd80f

M. Pletnikov, Y. Ayhan, O. Nicholskaia, M. Ovanesov, H. Huang et al., Inducible expression of mutant human DISC1 in mice is associated with brain and behavioral abnormalities reminiscent of schizophrenia, Molecular Psychiatry, vol.33, issue.2, pp.173-186, 2008.
DOI : 10.1016/S0166-2236(00)01886-5

D. Popa, C. Léna, C. Alexandre, and A. J. , Lasting Syndrome of Depression Produced by Reduction in Serotonin Uptake during Postnatal Development: Evidence from Sleep, Stress, and Behavior, Journal of Neuroscience, vol.28, issue.14, pp.3546-3554, 2008.
DOI : 10.1523/JNEUROSCI.4006-07.2008

R. D. Porsolt, A. Bertin, N. Blavet, M. Deniel, and M. Jalfre, Immobility induced by forced swimming in rats: Effects of agents which modify central catecholamine and serotonin activity, European Journal of Pharmacology, vol.57, issue.2-3, pp.201-210, 1979.
DOI : 10.1016/0014-2999(79)90366-2

D. J. Porteous and J. K. Millar, Disrupted in schizophrenia 1: building brains and memories, Trends in Molecular Medicine, vol.12, issue.6, pp.255-261, 2006.
DOI : 10.1016/j.molmed.2006.04.009

K. J. Powell, S. E. Hori, R. Leslie, A. Andrieux, H. Schellinck et al., Cognitive impairments in the STOP null mouse model of schizophrenia., Behavioral Neuroscience, vol.121, issue.5, pp.826-835, 2007.
DOI : 10.1037/0735-7044.121.5.826

URL : https://hal.archives-ouvertes.fr/inserm-00380034

E. D. Radomsky, G. L. Haas, J. J. Mann, and J. A. Sweeney, Suicidal Behavior in Patients With Schizophrenia and Other Psychotic Disorders, American Journal of Psychiatry, vol.156, issue.10, pp.1590-1595, 1999.
DOI : 10.1176/ajp.156.10.1590

J. W. Richardson-jones, C. P. Craige, and T. H. Nguyen, Serotonin-1A Autoreceptors Are Necessary and Sufficient for the Normal Formation of Circuits Underlying Innate Anxiety, Journal of Neuroscience, vol.31, issue.16, pp.6008-6018, 2011.
DOI : 10.1523/JNEUROSCI.5836-10.2011

C. A. Ross, R. L. Margolis, S. A. Reading, M. Pletnikov, and J. T. Coyle, Neurobiology of Schizophrenia, Neuron, vol.52, issue.1, pp.139-153, 2006.
DOI : 10.1016/j.neuron.2006.09.015

K. V. Savelieva, S. Zhao, V. M. Pogorelov, I. Rajan, Q. Yang et al., Genetic Disruption of Both Tryptophan Hydroxylase Genes Dramatically Reduces Serotonin and Affects Behavior in Models Sensitive to Antidepressants, PLoS ONE, vol.29, issue.10, p.3301, 2008.
DOI : 10.1371/journal.pone.0003301.s004

T. L. Schaefer, C. V. Vorhees, and M. T. Williams, Mouse plasmacytoma-expressed transcript 1 knock out induced 5-HT disruption results in a lack of cognitive deficits and an anxiety phenotype complicated by hypoactivity and defensiveness, Neuroscience, vol.164, issue.4, pp.1431-1443, 2009.
DOI : 10.1016/j.neuroscience.2009.09.059

C. Spielewoy, C. Roubert, M. Hamon, M. Nosten-bertrand, C. Betancur et al., Behavioural disturbances associated with hyperdopaminergia in dopamine-transporter knockout mice, Behavioural Pharmacology, vol.11, issue.3 & 4, pp.279-290, 2000.
DOI : 10.1097/00008877-200006000-00011

URL : https://hal.archives-ouvertes.fr/inserm-00126162

K. Talbot, The sandy (sdy) mouse: a dysbindin-1 mutant relevant to schizophrenia research, Prog. Brain Res, vol.179, pp.87-94, 2009.
DOI : 10.1016/S0079-6123(09)17910-4

K. Talbot, D. S. Cho, and W. Y. Ong, Dysbindin-1 is a synaptic and microtubular protein that binds brain snapin, Human Molecular Genetics, vol.15, issue.20, pp.3041-3054, 2006.
DOI : 10.1093/hmg/ddl246

S. Weiss, M. Nosten-bertrand, J. M. Mcintosh, B. Giros, and M. P. Martres, Nicotine Improves Cognitive Deficits of Dopamine Transporter Knockout Mice without Long-Term Tolerance, Neuropsychopharmacology, vol.18, issue.12, pp.2465-2478, 2007.
DOI : 10.1038/sj.npp.1301385

P. Willner, Animal models as simulations of depression, Trends in Pharmacological Sciences, vol.12, pp.131-136, 1991.
DOI : 10.1016/0165-6147(91)90529-2

I. Yalcin, C. Belzung, and A. Surget, Mouse strain differences in the unpredictable chronic mild stress: a four-antidepressant survey, Behavioural Brain Research, vol.193, issue.1, pp.140-143, 2008.
DOI : 10.1016/j.bbr.2008.04.021